Updated May 20, 2021 Reviewed by Andres F. Correa, MD These days, it can be tough to determine if and when you should be screened for prostate cancer. Screening recommendations have gone through significant shifts over the years. Men are urged to h...

After receiving a diagnosis of prostate cancer, it’s natural that your first instinct would be to begin treatment immediately. The idea of cancer growing in your body is, understandably, upsetting for many patients. But, prostate cancer treatments like surg...

When it comes to cancer, the term genetic is often used interchangeably with hereditary. But genetic and hereditary cancers aren’t always the same thing, and the difference could play an important role in how a cancer is treated. Understanding mutations ...

Current U.S. Preventive Services Task Force (USPSTF) recommendations state that men ages 55 to 69 should decide for themselves whether to undergo a prostate-specific antigen (PSA) test after discussing the potential benefits and harms with their doctor. ...

More than two decades ago, researchers identified harmful mutations in two genes—BRCA1 and BRCA2—that increased the risk of breast, ovarian, and other cancers. That landmark discovery led to a screening test for the mutations and helped many individuals mak...

What are lymph nodes—and what is their role in the spread of cancer? Knowing how the two are connected can help patients and their loved ones understand more about their diagnosis and treatment options. Here, Jeffrey Farma, MD, FACS, a surgical oncologist a...